Philip Arlen
Company: Precision Biologics
Job title: President & Chief Executive Officer
Seminars:
Roundtable Discussion:Individualized Cancer Vaccines: Development Strategies for Neoantigen Selection, Clinical Development & Regulatory Approval 1:30 pm
How to determine the best clinical setting for individualized cancer therapies for the easiest path through the clinic What are the different combination therapy strategies with personalized cancer vaccines for positive patient response? What is the dosing schedule in trials for personalized cancer vaccines for the most effective patient response?Read more
day: Conference Day Two